» Articles » PMID: 28295230

Microvesicles Released by Apoptotic Human Neutrophils Suppress Proliferation and IL-2/IL-2 Receptor Expression of Resting T Helper Cells

Overview
Journal Eur J Immunol
Date 2017 Mar 16
PMID 28295230
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Membrane-coated microvesicles (MVs) have been identified as important mediators in intercellular communication. During the process of apoptosis, dying cells dynamically release MVs. Neutrophils are the most abundant type of leukocytes in the circulation. Due to their very short lifespan, it is likely that they are the source of large amounts of apoptotic cell-derived MVs. Here, we show that MVs released by apoptotic human polymorphonuclear neutrophils (apoPMN-MVs), but not the apoptotic neutrophils themselves, selectively suppress the proliferation of CD25 (IL-2Rα) CD127 (IL-7Rα) Th cells in a dose-dependent manner. In contrast, the proliferation of total T cells is not affected by MVs. Importantly, apoPMN-MVs suppress the secretion of IL-2 as well as the expression of and signaling via the IL-2 receptor (IL-2R) by CD25 CD127 Th cells. Addition of IL-7 strongly reduced the suppression of T-cell proliferation by MVs and the addition of IL-2 completely abrogated the suppressive effect. Thus, apoPMN-MVs suppressed a subset of Th cells by downregulating IL-2 and IL-2R expression and signaling. This may represent an important mechanism to prevent the activation and expansion of resting T cells in the absence of sufficient cytokine stimulation, and thereby maintaining immune tolerance.

Citing Articles

New insights into constitutive neutrophil death.

Chen T, Ren Q, Ma F Cell Death Discov. 2025; 11(1):6.

PMID: 39800780 PMC: 11725587. DOI: 10.1038/s41420-025-02287-1.


Engineering strategies for apoptotic bodies.

Hu Z, Qian S, Zhao Q, Lu B, Lu Q, Wang Y Smart Med. 2024; 3(3):e20240005.

PMID: 39420952 PMC: 11425054. DOI: 10.1002/SMMD.20240005.


Extracellular Mechanisms of Neutrophils in Immune Cell Crosstalk.

Shrestha S, Hong C Immune Netw. 2023; 23(5):e38.

PMID: 37970234 PMC: 10643328. DOI: 10.4110/in.2023.23.e38.


Reigniting hope in cancer treatment: the promise and pitfalls of IL-2 and IL-2R targeting strategies.

Muhammad S, Fan T, Hai Y, Gao Y, He J Mol Cancer. 2023; 22(1):121.

PMID: 37516849 PMC: 10385932. DOI: 10.1186/s12943-023-01826-7.


Neutrophil-T cell crosstalk and the control of the host inflammatory response.

Bert S, Nadkarni S, Perretti M Immunol Rev. 2022; 314(1):36-49.

PMID: 36326214 PMC: 10952212. DOI: 10.1111/imr.13162.